IP Library Granted Patent US 12,168,795
Granted Patent B2
US 12,168,795 · App. 16/640,231 · Granted Dec 17, 2024

Method for measuring cholesterol in low-density lipoprotein, measurement reagent, and measurement kit

Inventors: Mizuki Miura (Shizuoka, JP); Tomoko Aratake (Shizuoka, JP); Kenta Kinjo (Shizuoka, JP)
Assignee: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
C12Q1/60C12Q1/32C12Q1/44G01N2333/902G01N2333/918G01N2405/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,168,795
App. No.
16/640,231
Granted
Dec 17, 2024
Kind
B2
Abstract

To provide a method for simply and precisely measuring cholesterol (LDL-C) in low-density lipoprotein in a sample without use of any surfactant having an alkylphenol structure, in terms of environmental friendliness. A method for measuring LDL-C in a sample, the method comprising: reacting the sample with (i) a combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) a combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase, in an aqueous solvent which comprises: [a] one or more surfactants selected from the group consisting of a polyoxyethylene alkyl ether and a polyoxyethylene polyoxypropylene alkyl ether; and [b] a polyoxyethylene polyoxypropylene copolymer; and which does not comprise any surfactant having an alkylphenol structure; and measuring a substance formed or consumed in the reaction.

Claims (42)

1. A method for measuring cholesterol in low-density lipoprotein in a sample, the method comprising:

mixing the sample and an aqueous solvent which comprises:

(i) a combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) a combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase,

one or more surfactants selected from the group consisting of a polyoxyethylene alkyl ether and a polyoxyethylene polyoxypropylene alkyl ether,

a polyoxyethylene polyoxypropylene copolymer and

a polyoxypropylene derivative not comprising any polyoxyethylene in a molecule, to react cholesterol in low-density lipoprotein in the sample with (i) the combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) the combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase; and

measuring a substance formed or consumed in the reaction from the low-density lipoprotein,

with the proviso that the aqueous solvent does not comprise any surfactant having an alkylphenol structure.

2. The method according to claim 1 , wherein the alkyl in the polyoxyethylene alkyl ether and the polyoxyethylene polyoxypropylene alkyl ether is independently an alkyl having 8 to 20 carbon atoms.

3. The method according to claim 1 , wherein the polyoxypropylene derivative is a polypropylene glycol or a polyoxypropylene glyceryl ether.

4. The method according to claim 1 , wherein the substance formed is a hydrogen peroxide.

5. The method according to claim 4 , wherein the hydrogen peroxide is measured using a reagent for measuring hydrogen peroxide.

6. The method according to claim 1 , wherein the substance formed is a reduced coenzyme.

7. The method according to claim 6 , wherein the reduced coenzyme is measured using a reagent for measuring a reduced coenzyme.

8. The method according to claim 1 , wherein the aqueous solvent comprises the cholesterol ester hydrolase and the cholesterol oxidase.

9. The method according to claim 8 , wherein the cholesterol ester hydrolase and the cholesterol oxidase are reacted with the sample, thereby forming hydrogen peroxide.

10. The method according to claim 8 , wherein alkyl in the polyoxyethylene alkyl ether and the polyoxyethylene polyoxypropylene alkyl ether is independently an alkyl having 8 to 20 carbon atoms.

11. The method according to claim 8 , wherein the polyoxypropylene derivative comprises a polypropylene glycol or a polyoxypropylene glyceryl ether.

12. The method according to claim 1 , wherein the aqueous solvent excludes polyoxyethylene alkyl ether.

13. The method according to claim 1 , wherein the aqueous solvent comprises the polyoxyethylene polyoxypropylene alkyl ether.

14. The method according to claim 1 , wherein the method excludes any removal of cholesterol in lipoprotein other than the low-density lipoprotein in a sample before measurement of the low-density lipoprotein-cholesterol.

15. The method according to claim 1 , wherein the sample comprises at least one selected from the group consisting of whole blood, plasma, and serum.

16. A method for measuring cholesterol in total low-density lipoprotein in a sample, the method comprising:

mixing the sample and an aqueous solvent which comprises:

(i) a combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) a combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase,

one or more surfactants selected from the group consisting of a polyoxyethylene alkyl ether and a polyoxyethylene polyoxypropylene alkyl ether,

a polyoxyethylene polyoxypropylene copolymer and

a polyoxypropylene derivative not comprising any polyoxyethylene in a molecule, to react cholesterol in low-density lipoprotein in the sample with (i) the combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) the combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase; and

measuring a substance formed or consumed in the reaction,

with the proviso that the aqueous solvent does not comprise any surfactant having an alkylphenol structure.

17. The method according to claim 16 , wherein

the substance formed or consumed in the reaction is measured from the low-density lipoprotein, and

the method excludes any removal of cholesterol in lipoprotein other than low-density lipoprotein in a sample before measurement of low-density lipoprotein-cholesterol.

18. A method for measuring cholesterol in low-density lipoprotein in a sample, the method comprising:

mixing the sample and an aqueous solvent which comprises:

(i) a combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) a combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase,

one or more surfactants selected from the group consisting of a polyoxyethylene alkyl ether and a polyoxyethylene polyoxypropylene alkyl ether,

a polyoxyethylene polyoxypropylene copolymer and

a polyoxypropylene derivative not comprising any polyoxyethylene in a molecule, to react cholesterol in low-density lipoprotein in the sample with (i) the combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) the combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase; and

measuring a substance formed or consumed in the reaction,

with the proviso that the aqueous solvent does not comprise any surfactant having an alkylphenol structure,

wherein the method excludes any removal of cholesterol in lipoprotein other than the low-density lipoprotein in a sample before measurement of the low-density lipoprotein-cholesterol.

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2020
From: MIURA, MIZUKI; ARATAKE, TOMOKO; KINJO, KENTA
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 051861/0836 →
Priority Claims (1)
JP 2017-168235 · Sep 1, 2017 · national
Continuity (1)
Related Publication 20200392558A1 · Dec 17, 2020